Hodgkin's Lymphoma: From Tumor Microenvironment to Immunotherapeutic Approach - Body's Own Power Protection Challenges

作者: Marylne Lejeune , Luis de la Cruz-Merino , Toms lvaro

DOI: 10.5772/34028

关键词:

摘要: Marylene Lejeune1, Luis de la Cruz-Merino2 and Tomas Alvaro3 1Molecular Biology Research Section, Hospital Tortosa Verge Cinta, IISPV, URV, 2Clinical Oncology Department, Universitario Virgen Macarena, Sevilla, Member of the Grupo Oncologico para el Tratamiento las Enfermedades Linfoides (GOTEL), 3Pathology Spain

参考文章(277)
Nikolaos Horianopoulos, Sevasti Kamina, Panagiotis Kitsoulis, Panagiotis Kanavaros, Maria Bai, Niki John Agnantis, Alexandra Papoudou-Bai, Cell cycle and apoptosis deregulation in classical Hodgkin lymphomas. in Vivo. ,vol. 19, pp. 439- 453 ,(2005)
Jun-ichiro Inoue, Takaomi Ishida, Nobuo Tsukamoto, Norihiko Kobayashi, Asuka Naito, Sakura Azuma, Tadashi Yamamoto, Tumor Necrosis Factor Receptor-Associated Factor (TRAF) Family: Adapter Proteins That Mediate Cytokine Signaling Experimental Cell Research. ,vol. 254, pp. 14- 24 ,(2000) , 10.1006/EXCR.1999.4733
B Falini, L Flenghi, F Aversa, G Barbabietola, M.F Martelli, P Comeli, P.L Tazzari, M.K Broe, H Stein, H Dürkop, G Pizzolo, A Bolognesi, F Stirpe, E Sabattini, S Pileri, Response of refractory Hodgkin's disease to monoclonal anti-CD30 immunotoxin The Lancet. ,vol. 339, pp. 1195- 1196 ,(1992) , 10.1016/0140-6736(92)91135-U
Hisamaru Hirai, Tsuyoshi Takahashi, Tadaichi Kitamura, Atsushi Kunisato, Takeshi Azuma, Human CD4+ CD25+ Regulatory T Cells Suppress NKT Cell Functions Cancer Research. ,vol. 63, pp. 4516- 4520 ,(2003)
Robert J. Kreitman, Wyndham H. Wilson, Jeffrey D. White, Maryalice Stetler-Stevenson, Elaine S. Jaffe, Steven Giardina, Thomas A. Waldmann, Ira Pastan, Phase I trial of recombinant immunotoxin anti-Tac(Fv)-PE38 (LMB-2) in patients with hematologic malignancies. Journal of Clinical Oncology. ,vol. 18, pp. 1622- 1636 ,(2000) , 10.1200/JCO.2000.18.8.1622
Stephen Hiscox, Peter Barrett-Lee, Robert I Nicholson, Therapeutic targeting of tumor--stroma interactions Expert Opinion on Therapeutic Targets. ,vol. 15, pp. 609- 621 ,(2011) , 10.1517/14728222.2011.561201
Edith A. Burns, Elaine A. Leventhal, Aging, immunity, and cancer. Cancer Control. ,vol. 7, pp. 513- 522 ,(2000) , 10.1177/107327480000700603
Martin R. Weihrauch, Oliver Manzke, Marc Beyer, Heinz Haverkamp, Volker Diehl, Heribert Bohlen, Juergen Wolf, Joachim L. Schultze, Elevated serum levels of CC thymus and activation-related chemokine (TARC) in primary Hodgkin's disease: potential for a prognostic factor. Cancer Research. ,vol. 65, pp. 5516- 5519 ,(2005) , 10.1158/0008-5472.CAN-05-0100
Nancy Lee Harris, Elaine S. Jaffe, Jacques Diebold, Georges Flandrin, H. Konrad Muller-Hermelink, James Vardiman, T. Andrew Lister, Clara D. Bloomfield, World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. Journal of Clinical Oncology. ,vol. 17, pp. 3835- 3849 ,(1999) , 10.1200/JCO.1999.17.12.3835